# Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction

> **NCT03169582** · PHASE4 · UNKNOWN · sponsor: **Eduardo Vargas-Baquero** · enrollment: 78 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Avanafil
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT03169582
- **Lead sponsor:** Eduardo Vargas-Baquero
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04-01
- **Primary completion:** 2018-06-01
- **Final completion:** 2018-06-01
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169582, "Avanafil Versus Sildenafil in Spinal Cord Injury Erectile Dysfunction". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03169582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*